Esperion Therapeutics

Esperion Therapeutics

Esperion Therapeutics

Esperion Therapeutics discovers and develops pharmaceutical products for the treatment of cardiovascular and metabolic diseases.
Founded
2008
Raised
$245.7M
Follow us
Alexa global traffic share
Twitter followers
Latest funding Show all
$189,900,000
Post-IPO equity - 2015
$33,000,000
Venture capital - 2013
Team Size
10+
Employees
Pulse 2.0

Esperion Therapeutics (ESPR) Stock: Why It Increased Today